Adverse effects of testosterone replacement therapy for men, a matched cohort study

2017 ◽  
Vol 16 (3) ◽  
pp. e448-e450 ◽  
Author(s):  
J. Hanske ◽  
N. Von Landenberg ◽  
P. Gild ◽  
A. Cole ◽  
W. Jiang ◽  
...  
2017 ◽  
Vol 197 (4S) ◽  
Author(s):  
Julian Hanske ◽  
Nicolas von Landenberg ◽  
Philipp Gild ◽  
Alexander P. Cole ◽  
Wei Jiang ◽  
...  

2019 ◽  
Vol 132 (9) ◽  
pp. 1069-1077.e4 ◽  
Author(s):  
Simone Y. Loo ◽  
Laurent Azoulay ◽  
Rui Nie ◽  
Sophie Dell’Aniello ◽  
Oriana Hoi Yun Yu ◽  
...  

2010 ◽  
Vol 9 (1) ◽  
pp. 59
Author(s):  
Polackwich AS ◽  
Tadros NN ◽  
Ostrowski KA ◽  
◽  
◽  
...  

Late onset hypogonadism (LOH) is an issue of increasing concern. Studies have shown the importance of testosterone in the maintenance of homeostasis, especially with respect to bone health, sexual function, diabetes, cardiovascular risk, mental health and cognition. Much of the dysfunction in hypogonadism can be reversed or improved with testosterone replacement therapy (TRT). Physicians worry about the possible consequences of TRT, especially regarding the prostate. By reviewing the literature, we have found there are significant benefits to TRT, and fears of adverse effects on the prostate are largely unfounded, though there is a great need for larger studies with longer periods of follow-up, especially to evaluate adverse events.


Sign in / Sign up

Export Citation Format

Share Document